Chemical Structure : PD180970
CAS No.: 287204-45-9
Catalog No.: PC-73114Not For Human Use, Lab Use Only.
PD180970 (PD 180970) is an ATP-competitive inhibitor of p210bcr/abl tyrosine kinase, inhibits autophosphorylation of p210Bcr-Abl with IC50 of 5 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $98 | In stock | |
10 mg | $158 | In stock | |
25 mg | $278 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
PD180970 (PD 180970) is an ATP-competitive inhibitor of p210 bcr/abl tyrosine kinase, inhibits autophosphorylation of p210Bcr-Abl with IC50 of 5 nM.
PD180970 selectively induces apoptosis in chronic myeloid leukemia (CML) K562 cells.
PD180970 inhibits in vivo tyrosine phosphorylation of Gab2, CrkL and p210bcr/abl (IC50, 80, 80 and 170 nM respectively).
PD180970 potently inhibits p210bcr/abl autophosphorylation in vitro (IC50=5 nM).
PD180970 also potently inhibits c-Src and KIT (IC50 , 0.8 and 50 nM, respectively).
PD180970 induces autophagy and reduces neuroinflammation in animal models of Parkinson's disease.
M.Wt | 429.27 | |
Formula | C21H15Cl2FN4O | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
6-(2,6-Dichlorophenyl)-2-[(4-fluoro-3-methylphenyl)amino]-8-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one |
1. J F Dorsey, et al. Cancer Res. 2000 Jun 15;60(12):3127-31.
2. Paul La Rosée, et al. Cancer Res. 2002 Dec 15;62(24):7149-53.
3. Suresh Sn, et al. EBioMedicine. 2019 Dec;50:260-273.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright